| __timestamp | Dr. Reddy's Laboratories Limited | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 5078000000 |
| Thursday, January 1, 2015 | 42585000000 | 4717000000 |
| Friday, January 1, 2016 | 45702000000 | 5096000000 |
| Sunday, January 1, 2017 | 46372000000 | 4986000000 |
| Monday, January 1, 2018 | 46910000000 | 4214000000 |
| Tuesday, January 1, 2019 | 48890000000 | 3806000000 |
| Wednesday, January 1, 2020 | 50129000000 | 3671000000 |
| Friday, January 1, 2021 | 54559000000 | 3528000000 |
| Saturday, January 1, 2022 | 62081000000 | 3445000000 |
| Sunday, January 1, 2023 | 105931000000 | 3498000000 |
| Monday, January 1, 2024 | 77201000000 | 3702000000 |
Cracking the code
In the competitive landscape of pharmaceuticals, effective cost management is crucial. Over the past decade, Dr. Reddy's Laboratories Limited and Teva Pharmaceutical Industries Limited have demonstrated contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Dr. Reddy's Laboratories saw a significant increase of approximately 173% in their SG&A expenses, peaking in 2023. In contrast, Teva's expenses showed a gradual decline, dropping by about 31% over the same period. This divergence highlights differing strategic approaches to cost management. Dr. Reddy's Laboratories' sharp rise in 2023 could indicate strategic investments or increased operational costs, while Teva's consistent reduction suggests a focus on efficiency and cost-cutting measures. Understanding these trends provides valuable insights into the financial strategies of these pharmaceutical giants.
Who Optimizes SG&A Costs Better? Novartis AG or Dr. Reddy's Laboratories Limited
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Bio-Techne Corporation
Teva Pharmaceutical Industries Limited vs Viking Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Mesoblast Limited
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Teva Pharmaceutical Industries Limited vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Halozyme Therapeutics, Inc.
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs CymaBay Therapeutics, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited and Geron Corporation: SG&A Spending Patterns Compared